- CEO
- Akash Bedi
- Full Time Employees
- 2,758
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- One Island East Hong Kong Hong Kong
- IPO Date
- Dec 17, 2010
- Business
- Health and Happiness (H&H) International Holdings Limited Health and Happiness (H&H) International Holdings Limited (1112.HK) is an investment holding company principally engaged in the manufacture and sale of pediatric nutrition and baby care, adult nutrition and care, and pet nutrition and care products; its core offerings span infant milk formulas, growing-up milks, and nutritional products for expectant and nursing mothers under the Baby Nutrition and Care (BNC) segment including the Biostime brand; probiotics and nutritional supplements for infants, children, and mothers; vitamins, herbal and mineral supplements, skin care, and sports nutrition under the Adult Nutrition and Care (ANC) segment featuring brands such as Swisse and Aurelia; and pet foods, treats, and supplements under the Pet Nutrition and Care (PNC) segment with brands like Solid Gold Pet, Zesty Paws, and Dodie; other pediatric products include dried baby foods and baby care items under brands like Good Goût. The company, founded in 1999 and formerly known as Biostime International Holdings Limited, maintains its headquarters at One Island East, Taikoo Place in Hong Kong, with a second head office in London and additional operations in Guangzhou, Melbourne, Paris, Singapore, Amsterdam, Bengaluru, Culver City, Bangkok, and Dubai; it serves consumer markets primarily in Mainland China, Australia, New Zealand, North America, and other international regions through premium brands backed by scientific research in a holistic family health approach targeting nutrition, probiotics, and wellness. In recent developments, the group reported a 4.9% revenue increase to RMB7,019.2 million for the first half of 2025 driven by growth across all three segments and higher-margin nutritional supplements, alongside operational efficiency gains that improved the adjusted EBITDA margin to 5.7%; it partnered with Centric Software in March 2025 to implement PLM technology for enhanced global R&D collaboration, product innovation, and digital transformation; formed a new alliance with Greater Good Charities in 2024 to support sustainability initiatives; and continued strategic focus on premiumization, high-margin products, and global expansion following the full rollout of reformulated infant formulas compliant with China's new GB standards in 2024, while pursuing B Corp certification targeted for 2025.